日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Assessing patient risk, benefit, and outcomes in drug development: A decade of ramucirumab clinical trials

评估药物研发中患者的风险、获益和结果：雷莫芦单抗临床试验十年回顾

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.7130
Khan, Adam; Khan, Hassan; Hughes, Griffin K; Ladd, Chase; McIntire, Ryan; Gardner, Brooke; Peña, Andriana M; Schoutko, Abigail; Tuia, Jordan; Minley, Kirstien; Haslam, Alyson; Prasad, Vinay; Vassar, Matt
发表日期：2024
文献求助 收藏

The Reporting and Methodological Quality of Systematic Reviews Underpinning Clinical Practice Guidelines Focused on the Management of Cutaneous Melanoma: Cross-Sectional Analysis

系统评价在皮肤黑色素瘤临床实践指南中的报告和方法学质量：横断面分析

期刊:JMIR Dermatology
影响因子:
doi:10.2196/43821
Khalid, Mahnoor; Sutterfield, Bethany; Minley, Kirstien; Ottwell, Ryan; Abercrombie, McKenna; Heath, Christopher; Torgerson, Trevor; Hartwell, Micah; Vassar, Matt
黑色素瘤
发表日期：2023
文献求助 收藏

Alcohol use disorder: An analysis of the evidence underpinning clinical practice guidelines

酒精使用障碍：临床实践指南的证据分析

期刊:Drug and Alcohol Dependence
影响因子:3.6
doi:10.1016/j.drugalcdep.2022.109287
Tanner, David; Minley, Kirstien; Snider, Kelsey; Hartwell, Micah; Torgerson, Trevor; Ottwell, Ryan; Beaman, Jason; Vassar, Matt
发表日期：2022
文献求助 收藏